ANI Pharmaceuticals | ANIP - Net Income


ANI Pharmaceuticals reported $32.35M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Canopy Growth CAD -62.63M 60.99M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Nektar Therapeutics USD -36.08M 978K Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Omeros USD -32.23M 23.81M Sep/2024
Perrigo USD -1.42B 1.43B Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025